Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Response and recurrence correlates in individuals treated with neoadjuvant anti-PD-1 therapy for resectable oral cavity squamous cell carcinoma

Published:2021-10 Issue:10 Volume:2 Page:100411
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Liu Sixue^ORCID,Knochelmann Hannah M.,Lomeli Shirley H.^ORCID,Hong Aayoung,Richardson Mary^ORCID,Yang Zhentao,Lim Raymond J.^ORCID,Wang Yan,Dumitras Camelia^ORCID,Krysan Kostyantyn,Timmers Cynthia^ORCID,Romeo Martin J.^ORCID,Krieg Carsten^ORCID,O’Quinn Elizabeth C.,Horton Joshua D.,Dubinett Steve M.^ORCID,Paulos Chrystal M.,Neskey David M.,Lo Roger S.^ORCID

Funder

National Institutes of Health

V Foundation for Cancer Research

Bristol-Myers Squibb

Melanoma Research Alliance

Jonsson Comprehensive Cancer Center

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference61 articles.

1. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer;Topalian;N. Engl. J. Med.,2012

2. Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease;Liu;Cancer Discov.,2016

3. Neoadjuvant versus adjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma;Blank;Nat. Med.,2018

4. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018

5. The molecular landscape of head and neck cancer;Leemans;Nat. Rev. Cancer,2018

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quantifiable TCR repertoire changes in prediagnostic blood specimens among patients with high-grade ovarian cancer;Cell Reports Medicine;2024-07

2. Anti‐PD‐(L)1‐Based Neoadjuvant Therapy in Head and Neck Carcinoma: a Meta‐analysis of Prospective Clinical Trials;Otolaryngology–Head and Neck Surgery;2024-06-29

3. Precision Medicine and Clinical Trials in Advanced and Metastatic Oral Cancer;Journal of Maxillofacial and Oral Surgery;2024-06-17

4. PD-1 inhibitor combined with paclitaxel and cisplatin in the treatment of recurrent and metastatic hypopharyngeal/laryngeal squamous cell carcinoma: efficacy and survival outcomes;Frontiers in Immunology;2024-05-17

5. Regulatory T‐cells activated in metastatic draining lymph nodes possibly suppress cancer immunity in cancer tissues of head and neck squamous cell cancer;Pathology International;2024-05-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3